Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Gabrielle Sulzberger, a director at Eli Lilly, acquired 9 shares of common stock through a deferral plan.

Summary

• Gabrielle Sulzberger, a director at Eli Lilly & Co, acquired 9 shares of common stock on December 18, 2023.
• The shares were acquired at a price of $579.76 per share.
• These shares were acquired as part of the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The shares will be settled in common stock after Ms. Sulzberger's separation from service.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. The sentiment is neutral to slightly positive.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the director's separation from service.

Industry Context

Director share acquisitions are a common occurrence in publicly traded companies and are often seen as a sign of confidence in the company's future performance.

Comparison to Industry Standards

• Director share acquisitions are a standard practice across publicly listed companies.
• The use of deferral plans for director compensation is also a common practice.
• The specific details of the plan and the timing of the share settlement are specific to Eli Lilly's compensation policies.

Stakeholder Impact

• The share acquisition by a director may be viewed positively by shareholders as it indicates confidence in the company's future.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Units, LLY, Gabrielle Sulzberger